(Q46591714)

23 December 2017

title

Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula (English)

1 reference

23 December 2017

1 reference

2

Keiichi Fujiwara

1 reference

23 December 2017

author name string

Shoji Nagao

1

1 reference

23 December 2017

Noriaki Imafuku

3

1 reference

23 December 2017

Reina Kagawa

4

1 reference

23 December 2017

Yoshiaki Kozuka

5

1 reference

23 December 2017

Takashi Oda

6

1 reference

23 December 2017

Kenichiro Maehata

7

1 reference

23 December 2017

Hiroyasu Ishikawa

8

1 reference

23 December 2017

Hirofumi Koike

9

1 reference

23 December 2017

Eriko Aotani

10

1 reference

23 December 2017

Ichiro Kohno

11

1 reference

23 December 2017

language of work or name

English

0 references

publication date

11 July 2005

1 reference

23 December 2017

published in

Gynecologic Oncology

1 reference

23 December 2017

volume

99

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

327-333

1 reference

23 December 2017

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

The Gynecologic Oncology Group experience in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Clinical pharmacokinetics and dose optimisation of carboplatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Estimation of glomerular filtration rate in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Letter: Creatinine clearance: bedside estimate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Prediction of carboplatin clearance from standard morphological and biological patient characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Formula-based dosing for carboplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Glomerular number and size in relation to age, kidney weight, and body surface in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.003

10.1016/J.YGYNO.2005.06.003

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017